CRON Cronos Group Inc: Net earnings per share for the last 12 months

Oversupply risks and the tax burden are hindering the profitability of Cronos Group Inc. The annual EPS TTM trend shown on GURU.Markets visualizes this process, where the parameter has settled at 62.60. Margins are stagnating due to marketing expenses, yet scaling potential remains hidden in R&D and the biosynthesis of rare components via fermentation.
CRON (Cronos Group): analytical breakdowns and indicator data
- current price and projected stock value:
- company stock capitalization data:
- book capitalization data:
- company total debt and liquidity indicators:
- earnings and market multiples details:
CRON - Net Profit|Projected Net Profit Cronos Group Inc.|CRON - Price to Earnings Ratio|Future Price to Earnings Multiple Cronos Corp|CRON - Price/Earnings to Growth Ratio|Company Value to EBITDA Cronos Group|CRON - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Cronos Group|CRON - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months thecronosgroup.com|CRON - Net earnings per share growth this year|Expected earnings per share trend next year Cronos Group Inc.
- revenue and sales details:
Initial company analysis:CRON, Cronos Group Inc

Cronos Group Inc. (CRON) technological advantage in cannabinoid synthesis directly impacts margins, as quantified by the net earnings per share dynamics over the last twelve months. By analyzing the historical EPS YoY TTM delta, an investor determines the actual pace of business scaling, where abnormal growth peaks often signal market overheating and the risk of a subsequent price correction.
Competitor analysis
Earnings per share for the trailing year INDV (Indivior plc)|Collegium Corp (COLL) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Tweed|HITI (High Tide Inc.) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) auroramj.com|Net earnings per share (EPS TTM) ACHV|Net earnings per share (EPS TTM) Skye Bioscience (SKYE)|Net earnings per share (EPS TTM) ANEB (anebulo.com)|Earnings per share for the last four quarters INCR (Canndoc)|NTRB - Earnings per share for the last twelve months|NSRX - Net earnings per share (EPS TTM)|IGC: Net earnings per share (EPS TTM)|MIRA Pharma - Earnings per share for the trailing year|Net earnings per share for the last 12 months FLGC|Earnings per share for the last 12 months IMCC (imcannabis.com)|Earnings per share for the last twelve months adialpharma.com (ADIL)|ARTL (Artelo Biosciences, Inc.) - Earnings per share for the trailing year|Ensysce Biosciences - Net earnings per share for the last 12 months|Earnings per share for the trailing year TTNP|gnln.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year INM (InMed)|Akanda Corp. (AKAN) - Earnings per share for the last twelve months|ENVB - Net earnings per share for the last four quarters|BGXX (Bright Green Corp.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Hempacco Co., Inc. HPCO